MétaCan
Menu
← Back to cohort
Record W2088766774 · doi:10.3821/145.2.cpj64

A Role for Pharmacists in Respiratory Education

2012· article· en· W2088766774 on OpenAlexvenueaboutno aff
Kristine Petrasko

Bibliographic record

VenueCanadian Pharmacists Journal / Revue des Pharmaciens du Canada · 2012
Typearticle
Languageen
FieldMedicine
TopicAsthma and respiratory diseases
Canadian institutionsnot available
Fundersnot available
KeywordsMedicineAsthmaPharmacyIntervention (counseling)Pulmonary diseasePatient educationFamily medicineSession (web analytics)Medical prescriptionIntensive care medicineNursingInternal medicine

Abstract

fetched live from OpenAlex

In one of this issue's research briefs, “Community pharmacy– based medication management program in asthma and chronic obstructive pulmonary disease,”1 Beauchesne and colleagues discuss a study of Quebec pharmacists who assessed patients with asthma and chronic obstructive pulmonary disorder. The largest barrier to this intervention was the lack of time available. That's the bottom line for pharmacists — we need more time with our patients. Our training gives us a false impression of what we are going to be doing when we get out into practice. We are the medication experts (and often the educators), but are just not used in the way we should be. More often than not, we spend more time dispensing medications than talking to our patients. On average, a complete respiratory interview (and education session) takes about 1–2 hours (the pharmacists in this current study found it took at least 30 minutes for the interview1). A complete patient history and assessment of the patient's breathing problems usually comprises 30–60 minutes. The remaining hour involves education on any issues identified, including dispelling any myths the patients may have brought with them. We can often dig further and determine what triggers may be causing their symptoms, find ways they can avoid them, discuss any concerns they may have, monitor their drug therapy, provide advice to improve adherence issues and, most importantly, ensure their device technique is correct. Approximately 70% of patients may be using their inhalers incorrectly.2 In many cases, poor or incorrect technique is the root cause of patients not having success with their medication therapy. So, can this be easily done in the community pharmacy setting (and is it practical)? Not when the pharmacy is busy and there are other patients waiting for your time and attention. Could you book an appointment? Absolutely! But do the patients themselves really understand what this is all about? The person in need of education probably doesn't even realize what you can do for them. They often may not believe they have the “time” for this either. We need to educate our patients on what we can really do for them and why it is important. Something certainly changes when you say to a patient, “Hi, I'm the pharmacist and we can take the next 45 minutes to an hour together talking about your asthma.” Suddenly, he or she has lots to tell us and there is lots that we can do to help! Remind your patients that time spent with their pharmacist can help them avoid unnecessary trips to the doctor and/or emergency. If you are not fortunate enough to have a practice site that routinely provides you with the time to do in-depth consultations, realize that even with only 3–5 minutes available, you can still make a difference to your patients with asthma and/or COPD. At each visit, consider choosing at least 1 or 2 questions to focus on: Are they using their inhaler correctly? (Ideally this should be considered at every visit.) Are they using a spacer with their MDI? Are they using it correctly? Are they rinsing and spitting after each inhaled corticosteroid use? (Even if they use a spacer). Are they avoiding their triggers? Do they know what their triggers are? Is their asthma under good control? (As many as 60% of patients do not have their asthma under good control, and many assume this is normal.3,4) Do they have an action plan? This is recommended for all respiratory patients. Do they smoke? (Cigarettes/marijuana) How often are they using the short-acting beta 2 agonist? Consider overusage. These are just a few of the many questions we should ask our respiratory patients. If you are asking about a patient's device technique, ask him to show you how he is using it. You may have placebo versions of common inhalation devices (available from most manufacturers), or ask your patient to show you with his or her own medication. This is a teachable moment for many and often gets patients interested enough to come back and see you again at a less busy time to talk more about their condition. The Respiratory Training and Educator Course (RESPTrec), created for health care professionals by the Lung Associations of Saskatchewan and Manitoba, can give you the confidence to do this in your high-paced practice setting, plus provide you with any tools you may require.5 With change upon us in many provinces, we need to develop new approaches to the reimbursement models in our pharmacies. New scopes of practice are coming our way, and we need to be charging for our nondispensing services. One BC asthma study6 demonstrated how pharmacists providing “enhanced” care vs “usual” care helped patients better self-manage their condition, resulting in fewer symptoms, less missed work and improved quality of life. The evidence is there — patients in the enhanced care group also had 75% fewer emergency room visits over those in the usual care group.6 Pharmacist services are valuable, and charging for these services shows the value to our patients. If you are just starting to move in this direction, you can start by providing your patients with an invoice so they can at least see that there is a value attached to the service. Look to your peers who are providing this type of patient care, ask for ideas and share your own. This is the only way we are going to be able to fulfill our potential and truly help our patients.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.029
metaresearch head score (Gemma)0.053
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: Not applicable
GenreCandidate signal: Commentary · Consensus signal: Commentary
Teacher disagreement score0.030
Threshold uncertainty score0.155

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0290.053
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0020.001
Science and technology studies0.0110.005
Scholarly communication0.0110.019
Open science0.0040.023
Research integrity0.0180.027
Insufficient payload (model declined to judge)0.0300.006

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.033
GPT teacher head0.313
Teacher spread0.280 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreCommentary

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations2
Published2012
Admission routes2
Has abstractyes

Explore more

Same venueCanadian Pharmacists Journal / Revue des Pharmaciens du Canada→Same topicAsthma and respiratory diseases→French-language works237,207→